Bringing the fundamentals into focus…
Back to Assembly Biosciences, Inc.
How Assembly Biosciences, Inc. stacks up
ASMB · against 409 other Healthcare companies of similar size
Profitability
33/ 100
Below the middle of the pack.
Ranked #243 of 410 · scores higher than 40% of peers
Bars: peers in each 10-point band of the profitability score57 peers with a profitability score of 30–39, including ASMB · Click a bar to see the companies
Why profitability scores 33?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 76% of peers. Operating margin: -11.8% vs peer median 7.1%
- a lower return on invested capital: weaker than 69% of peers. Return on invested capital: -2.5% vs peer median 4.7%
- Return on assets is close to the peer norm. Return on assets: -0.0% vs peer median 1.7%
Metric by metric
Position: dot = ASMB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ASMB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 380 reported | -2.5% | 1.1% | 41% | 33% | |
| Operating marginHigher is better · 382 reported | -11.8% | 3.5% | 29% | 33% | |
| Return on assetsHigher is better · 409 reported | -0.0% | 0.5% | 48% | 33% | |
| Return on equityHigher is better · 389 reported | -0.0% | 0.0% | 50% | Context only | |
| Gross marginHigher is better · 429 reported | 15.0% | 38.5% | 22% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around ASMB| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 609M USD | 99 | 91 | |
| 5 | 4.4B CNY (≈$611M) | 98 | 77 | |
| 243 | 2.9B CNY (≈$412M) | 33 | 22 | |
| 243 | 3.3B CNY (≈$463M) | 33 | 26 | |
| 243 | 3.2B CNY (≈$449M) | 33 | 35 | |
| 243 | 2.5B CNY (≈$344M) | 33 | 28 | |
| 243 | 406M USD | 33 | 59 | |
| 249 | 2.2B CNY (≈$308M) | 32 | 18 | |
| 249 | 1.9B CNY (≈$270M) | 32 | 17 | |
| 249 | 1.9B CNY (≈$262M) | 32 | 24 | |
| 249 | 3.6B CNY (≈$506M) | 32 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score